The failure of biology to identify the molecular causes of disease has led to disappointment in the rate of development of new medicines. By combining the power of community-based modeling with broad access to large datasets on a platform that promotes reproducible analyses we can work towards more predictive molecular maps that can deliver better therapeutics

Christine Suver

David Henderson

Jonathan Derry

Jonathan Izant

Lara Mangravite

Matt Furia

Michael Kellen

Solveig Sieberts

Stephen Friend

Xavier Schildwachter

Crossref

Nature Precedings

English

A network view of disease and compound screening. Nature reviews. Drug discovery 8,

A novel signaling pathway impact analysis. Bioinformatics (Oxford,

An integrative genomics approach to infer causal associations between gene expression and disease.

Building a biomedical ontology recommender web service.

Building a chain of trust.

Can the pharmaceutical industry reduce attrition rates.

Computational disease modeling - fact or fiction? BMC systems biology 3,

Computer science. Accessible reproducible research.

Dataʼs shameful neglect.

Electronic consent channels: preserving patient privacy without handcuffing researchers. Science translational medicine 3,

Expression Omnibus at

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Genetic Information Nondiscrimination Act.

Genetics of gene expression and its effect on disease.

Genomic analysis of metabolic pathway gene expression in mice. Genome biology 6,

Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM. Bioinformatics (Oxford,

Integrating large-scale functional genomic data to dissect the complexity of yeast regulatory networks.

Network biology: understanding the cellʼs functional organization. Nature reviews.

Omics data sharing.

PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes.

Post-publication sharing of data and tools.

Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewers.

Reproducible research: a bioinformatics case study. Statistical applications in genetics and molecular biology 4,

Rewiring of genetic networks in response to DNA damage.

Sharing Data from Large-scale Biological Research Projects: A System of Tripartite Responsibility.

Sharing Policy and Implementation Guidance

Something in common. Science translational medicine 2,

Systematic documentation and analysis of human genetic variation in hemoglobinopathies using the microattribution approach.

The Fourth Paradigm: Data Intensive Scientific Discovery.

The Health Insurance Portability and Accountability Act of

The human genome at ten.

The need and drive for open data in biomedical publishing.

The need for precompetitive integrative bionetwork disease model building. Clinical pharmacology and therapeutics 87,

The transcriptional network for mesenchymal transformation of brain tumours.

Uncovering regulatory pathways that affect hematopoietic stem cell function using “genetical genomics”.

Variations in DNA elucidate molecular networks that cause disease.

Wavelab and reproducible research.

Why data-sharing policies matter.

Developing Predictive Molecular Maps of Human Disease through Community-based Modeling